Daily salbutamol in young patients with SMA type II-Reference-Cited by-同舟云学术

Daily salbutamol in young patients with SMA type II

Published:2008-07 Issue:7 Volume:18 Page:536-540
ISSN:0960-8966
Container-title:Neuromuscular Disorders
language:en
Short-container-title:Neuromuscular Disorders

Author:

Pane Marika,Staccioli Susanna,Messina Sonia,D’Amico Adele,Pelliccioni Marco,Mazzone Elena S.,Cuttini Marina,Alfieri Paolo,Battini Roberta,Main Marion,Muntoni Francesco,Bertini Enrico,Villanova Marcello,Mercuri Eugenio

Publisher

Elsevier BV

Subject

Genetics (clinical),Neurology (clinical),Neurology,Pediatrics, Perinatology and Child Health

Reference20 articles.

1. β2-Agonist administration reverses muscle wasting and improves muscle function in aged rats;Ryall;J Physiol,2004

2. Salbutamol, a β2-adrenoceptor agonist, increases skeletal muscle strength in young men;Martineau;Clin Sci (Lond),1992

3. The effects of albuterol and isokinetic exercise on the quadriceps muscle group;Caruso;Med Sci Sport Exer,1995

4. Increased muscle strength in paralyzed patients after spinal cord injury: effect of β-adrenergic agonist;Signorile;Arch Phys Med Rehabil,1995

5. Pilot trial of albuterol in spinal muscular atrophy;Kinali;Neurology,2002

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Therapeutic Options and Repurposed Drugs for Neurodegeneration;Advances in Diagnostics and Immunotherapeutics for Neurodegenerative Diseases;2024-07-28

2. Efficacy and safety of salbutamol in treatment of children with later-onset spinal muscular atrophy;Journal of Zhejiang University (Medical Sciences);2023-12-01

3. Spinal Muscular Atrophy: The Past, Present, and Future of Diagnosis and Treatment;International Journal of Molecular Sciences;2023-07-26

4. Respiratory considerations in patients with neuromuscular disorders;Muscle & Nerve;2023-05-29

5. New therapies for spinal muscular atrophy: where we stand and what is next;European Journal of Pediatrics;2023-04-17